Boehm, Michael, Butler, J., Filippatos, G., Ferreira, J. P., Pocock, S. J., Abdin, A., Mahfoud, F., Brueckmann, M., Gollop, N. D., Iwata, T., Ponikowski, P., Wanner, C., Zannad, F., Packer, M. and Anker, S. D.
(2022)
Empagliflozin improves cardiovascular and renal outcomes in patients with preserved ejection fraction irrespective of age:insights from the EMPEROR-Preserved trial.
European Journal of Heart Failure, 24 (S2).
pp. 131-132.
ISSN 1388-9842
Full text not available from this repository.
Actions (login required)
 |
View Item |
Tools
Tools